Dean Y. Li - 21 Apr 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
21 Apr 2023
Net transactions value
$0
Form type
4
Filing time
04 Oct 2023, 17:46:09 UTC
Previous filing
05 Apr 2023
Next filing
03 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1,659 +0.13% $0.000000 1,326,415 02 Oct 2023 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -627,705 -100% $0.000000* 0 21 Apr 2023 By Dean Y. Li 2021 GRAT F2
holding RXRX Class A Common Stock 1,422,048 21 Apr 2023 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 450,000 21 Apr 2023 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
F2 Reflects 687,295 shares transferred to the Reporting Person from the Dean Y. Li 2021 GRAT